Sabrkhany, S., Griffioen, A
Ketamine and psilocybin each produce a brief acute experience but set off a wave of synaptic growth afterward, ketamine through glutamate release and mTOR-dependent synapse formation and psilocybin through rapid, lasting growth of dendritic spines in the frontal cortex, both via BDNF signaling, which is why a single session can shift symptoms for weeks
Lets check a baseline TSH and repeat it in 48 weeks if we try it, and call sooner with new symptoms." It is brief, practical, and actionable
10.1093/ajh/hpaa044 [DOI] [PMC free article] [PubMed] [Google Scholar] 210.Hughes, K
Table of Contents What the PCAC meeting could change and what it cannot Most peptide prescribing today happens outside the legal compounding framework The evidence base, what physicians need to know before prescribing Informed consent for compounded peptide prescribing Compounding pharmacy verification, what physicians must confirm Practice infrastructure, four requirements before the first patient Medical board and malpractice exposure, an honest assessment How Topflight Apps can help What the PCAC meeting could change and what it cannot A positive PCAC recommendation followed by FDA rulemaking would create a legal 503A compounding pathway for the listed peptides
